Models
MAKERS LABORATORIES LTD.MAKERSLPharmaceuticals & Biotechnology
₹-3per share · Base Model Note
Revenue growth, the horizon and scenarios are yours to change. Every other input is part of the Trader plan; saving, sharing a saved link and the live-formula workbook are part of the Institutional plan.
Scenario
Value per share, your model₹(3)implied FY26 P/E (0.6)× · EV/EBITDA 0.2×
Against CMP ₹188.01−101.4%close of 28 Oct 2026
Growth the CMP implies—%no growth rate between −20% and 45% a year brings the value to the CMP on your other inputs
Value after FY31-36%share of enterprise value in the terminal
This figure is the arithmetic of your inputs and nothing else. MarketPing publishes no fair value, target or rating; the model is yours.
Where the methods land · ₹ per share · the dashed line is the CMP
DCF, rate ±1 · growth ±1your model across the sensitivity grid
₹(4)₹(2)
52-week rangetraded range, a fact not a value
₹150₹236
From enterprise to equity · ₹ crore
| PV of FY27–FY31 free cash flow | 5 |
| PV of terminal value | (1) |
| Enterprise value | 3 |
| less net debt | (5) |
| less non-controlling interest | 0 |
| add non-operating investments | 0 |
| Equity value | (2) |
| ÷ 0.59 crore shares | ₹(3) |
Free cash flow, filed and modelled · ₹ '000 crore
Filed, cash from operations − capexModelled free cash flow to firm
Sensitivity · ₹ per share
Down Across| WACC ↓terminal growth → | 4.0% | 4.5% | 5.0% | 5.5% | 6.0% |
|---|---|---|---|---|---|
| 10.00% | (3) | (3) | (3) | (3) | (4) |
| 10.50% | (2) | (3) | (3) | (3) | (3) |
| 11.00% | (2) | (2) | (3) | (3) | (3) |
| 11.50% | (2) | (2) | (2) | (3) | (3) |
| 12.00% | (2) | (2) | (2) | (2) | (3) |
The outlined cell is your model. Green figures sit above the CMP of ₹188.01; n/a marks a terminal growth at or above the discount rate. Steps: WACC and terminal growth ±0.5 point, growth ±2, margin ±1.
Distribution of outcomes · 4,000 draws · growth, margin and the discount rate vary together
| 10th · 50th · 90th percentile, ₹ per share | (97) · (2) · 70 |
| Draws below the CMP | 100% |
| Rank correlation with revenue growth | −0.79 |
| Rank correlation with ebitda margin | +0.60 |
| Rank correlation with discount rate | +0.01 |
Each driver is drawn from a PERT distribution between the lowest and highest value across your scenarios (or ±50% growth, ±20% margin when there is one scenario), with the discount rate ±1.5 points. Seeded, so the same inputs give the same picture.
Projected cash flow to the firm · ₹ crore
History Forward| ₹ crore | FY23 | FY24 | FY25 | FY26 | FY27 | FY28 | FY29 | FY30 | FY31 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 101 | 104 | 121 | 141 | 164 | 191 | 222 | 259 | 302 |
| growth % | (20.0) | 3.1 | 15.7 | 16.4 | 16.5 | 16.5 | 16.5 | 16.5 | 16.5 |
| EBITDA | 3 | 1 | 8 | 15 | 17 | 20 | 23 | 27 | 32 |
| margin % | 3.2 | 1.0 | 6.3 | 10.5 | 10.5 | 10.5 | 10.5 | 10.5 | 10.5 |
| less depreciation | (4) | (5) | (5) | (5) | (5) | (6) | (7) | (8) | (10) |
| EBIT | (1) | (3) | 3 | 10 | 12 | 14 | 16 | 19 | 22 |
| less tax on EBIT | (3) | (4) | (4) | (5) | (6) | (6) | |||
| NOPAT | 7 | 8 | 10 | 11 | 13 | 16 | |||
| add depreciation | 4 | 5 | 5 | 5 | 5 | 6 | 7 | 8 | 10 |
| less capex | (13) | (7) | (4) | (4) | (4) | (6) | (7) | (9) | (12) |
| less working-capital build | — | (7) | (9) | (10) | (12) | (14) | |||
| Free cash flow to firm | (22) | (6) | (8) | — | 2 | 2 | 1 | 1 | (0) |
| Discount factor | 0.949 | 0.855 | 0.770 | 0.694 | 0.625 | ||||
| Present value | 2 | 1 | 1 | 0 | (0) |
History columns are the filed years (free cash flow there is cash from operations − capex, as filed); the base year and everything to its right come from the engine. Forward is the explicit horizon of the model itself: 3, 5 or 10 years, then flat.
The three statements, projected · ₹ crore · debt held at 5, dividends at 0% of profit
| ₹ crore | FY26 | FY27 | FY28 | FY29 | FY30 | FY31 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| EBIT | 10 | 12 | 14 | 16 | 19 | 22 |
| Interest at 18.9% on debt | (1) | (1) | (1) | (1) | (1) | |
| Profit before tax | 11 | 13 | 15 | 18 | 21 | |
| Profit after tax | 2 | 8 | 9 | 11 | 13 | 15 |
| Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance sheet, year end | ||||||
| Cash | 0 | 2 | 3 | 3 | 3 | 3 |
| Working capital | 45 | 53 | 61 | 71 | 83 | 97 |
| Net block and other assets | 121 | 120 | 120 | 120 | 121 | 123 |
| Debt | 5 | 5 | 5 | 5 | 5 | 5 |
| Equity | 122 | 130 | 139 | 150 | 163 | 178 |
| Balance check | 0 | 0 | 0 | (0) | 0 | (0) |
| Cash flow | ||||||
| From operations | 6 | 7 | 8 | 9 | 11 | |
| Investing (capex) | (4) | (6) | (7) | (9) | (12) | |
| Financing (dividends) | 0 | 0 | 0 | 0 | 0 | |
| Net change in cash | 1 | 1 | 1 | 0 | (1) | |
| Free cash flow to equity | 1 | 1 | 1 | 0 | (1) | |
Other liabilities are held at their FY26 level, so the check tests only what the model moves: cash, working capital, net block and other assets, debt and equity. A non-zero check would mean the three statements no longer tie.
Scenarios side by side · ₹ per share
| Scenario | Template | Growth | Margin | Rate | Terminal | ₹ / share | vs CMP |
|---|---|---|---|---|---|---|---|
| Base · editing | DCF | 16.5% | 10.5% | 11.00% | 5% | ₹(3) | (101.4)% |
A scenario is a full set of inputs under a name. Keep Base as the filed history carried forward; add Bull and Bear by saving the current inputs under those names and moving the two or three assumptions you actually hold a view on. The distribution above draws each driver between the lowest and highest value across your scenarios, so three scenarios give it a real range; with one scenario it falls back to fixed bands.